|Slideshows|December 23, 2015
Neuro News Roundup: Stroke Risks & Treatments
Author(s)Mark L. Fuerst
The risks and benefits of intravenous tissue plasminogen activator and endovascular thrombectomy are discussed in the following slides.
Advertisement
 Â
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- Perispinal Etanercept Shows No Efficacy in Treating Chronic Stroke
September 16th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Stem Cells of Secondary Progressive Multiple Sclerosis Drive Increased Proinflammatory T-Cell Activity
2
Postmortem Analysis Reveals Distinct Patterns of Aquaporin-4 in Parkinson Disease and Multiple System Atrophy
3
EMA Approves Semaglutide as First GLP-1 RA for Cardiovascular, Stroke-Related Benefits
4
Perispinal Etanercept Shows No Efficacy in Treating Chronic Stroke
5